MBD4 anticorps (C-Term)
-
- Antigène Voir toutes MBD4 Anticorps
- MBD4 (Methyl-CpG Binding Domain Protein 4 (MBD4))
-
Épitope
- C-Term
-
Reactivité
- Humain
-
Hôte
- Lapin
-
Clonalité
- Polyclonal
-
Conjugué
- Cet anticorp MBD4 est non-conjugé
-
Application
- Western Blotting (WB)
- Réactivité croisée
- Humain, Souris, Rat (Rattus)
- Réactivité croisée (Details)
- Calculated cross reactivity: Hu Mo Rt
- Attributs du produit
- MBD4 (MED1, Methyl-CpG-binding endonuclease 1, Methyl-CpG-binding protein MBD4, Mismatch-specific DNA N-glycosylase)
- Purification
- Purified by immunoaffinity chromatography.
- Immunogène
- A synthetic peptide corresponding to a sequence at the C-terminal of human MBD4, identical to the related rat and mouse sequences.
- Isotype
- IgG
- Top Product
- Discover our top product MBD4 Anticorps primaire
-
-
- Indications d'application
- Optimal working conditions should be determined by the investigator.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Reconstitution: Add 0.2 mL of distilled water will yield a concentration of 500 μg/mL.
- Buffer
- Supplied as a lyophilized powder. Each vial contains 5 mg BSA, 0.9 mg NaCl, 0.2 mg Na2HPO4, 0.05 mg Thimerosal, 0.05 mg Sodium azide.
- Agent conservateur
- Sodium azide, Thimerosal (Merthiolate)
- Précaution d'utilisation
- This product contains Sodium azide and Thimerosal (Merthiolate): POISONOUS AND HAZARDOUS SUBSTANCES which should be handled by trained staff only.
- Stock
- 4 °C,-20 °C
- Stockage commentaire
- 4°C/-20°C
-
- Antigène
- MBD4 (Methyl-CpG Binding Domain Protein 4 (MBD4))
- Autre désignation
- MBD4 (MBD4 Produits)
- Synonymes
- anticorps MED1, anticorps Med1, anticorps methyl-CpG binding domain 4, DNA glycosylase, anticorps methyl-CpG binding domain protein 4, anticorps methyl-CpG binding domain 4 DNA glycosylase, anticorps MBD4, anticorps Mbd4
- UniProt
- O95243
- Pathways
- Réparation de l'ADN
-